CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Shares, par value (euro)0.12 per share
Symbol
CVAC
Shares outstanding
22,421,536
Price per share
$4.66
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,925,242
Total reported value
$26,569,752
% of total 13F portfolios
0%
Share change
-13,347,053
Value change
-$73,373,470
Number of holders
55
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 55 institutional investors reported holding 5,925,242 shares of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC). This represents 26% of the company’s total 22,421,536 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) together control 26% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.7% 1,954,565 +92% 0% $8,834,634
ODDO BHF ASSET MANAGEMENT SAS 2.9% 650,557 0.11% $2,940,518
BANK OF AMERICA CORP /DE/ 2.4% 548,367 +24% 0% $2,478,619
CSS LLC/IL 2.3% 506,847 +85% 0.13% $2,290,948
NORTHERN TRUST CORP 1.5% 339,391 -4.3% 0% $1,534,048
CITADEL ADVISORS LLC 1.2% 261,097 +123% 0% $1,180,158
JANE STREET GROUP, LLC 0.91% 203,665 +175% 0% $865,920
TWO SIGMA INVESTMENTS, LP 0.86% 193,034 +162% 0% $872,514
D. E. Shaw & Co., Inc. 0.55% 124,432 -16% 0% $562,433
Point72 Asset Management, L.P. 0.53% 118,744 0% $536,723
STATE STREET CORP 0.52% 117,128 -6.2% 0% $529,419
GEODE CAPITAL MANAGEMENT, LLC 0.5% 111,185 -51% 0% $502,556
Optiver Holding B.V. 0.42% 94,949 +1912% 0.01% $429,169
DekaBank Deutsche Girozentrale 0.38% 85,642 0% 0% $233,000
UBS Group AG 0.29% 64,879 -84% 0% $293,253
Y-Intercept (Hong Kong) Ltd 0.26% 57,353 0.01% $259,236
Creative Planning 0.19% 42,676 -3.3% 0% $192,896
QUADRANT CAPITAL GROUP LLC 0.18% 39,311 -3.8% 0.01% $177,686
MORGAN STANLEY 0.16% 36,448 -82% 0% $164,746
BNP PARIBAS FINANCIAL MARKETS 0.16% 36,334 0% 0% $164,230
Ballentine Partners, LLC 0.16% 35,357 -6.5% 0% $159,814
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 0.15% 33,669 -19% 0% $152,184
Leonteq Securities AG 0.12% 28,000 0.01% $126,560
TWO SIGMA ADVISERS, LP 0.12% 27,400 0% $123,848
Zurcher Kantonalbank (Zurich Cantonalbank) 0.12% 26,105 -54% 0% $117,995

Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,925,242 $26,569,752 -$73,373,470 $4.52 55
2025 Q3 19,565,976 $105,428,086 +$42,943,344 $5.39 93
2025 Q2 11,518,381 $62,488,985 +$21,426,773 $5.43 88
2025 Q1 7,872,317 $21,841,913 -$777,543 $2.77 81
2024 Q4 7,855,201 $26,621,771 -$5,836,624 $3.41 74
2024 Q3 11,129,364 $32,809,500 -$7,039,565 $2.94 78
2024 Q2 14,229,273 $48,278,571 -$9,342,638 $3.40 85
2024 Q1 15,940,182 $48,278,751 -$19,660,440 $3.03 88
2023 Q4 22,199,014 $93,446,194 -$57,799,701 $4.21 88
2023 Q3 33,716,537 $230,128,246 -$14,892,714 $6.83 84
2023 Q2 35,746,141 $372,596,379 -$7,716,451 $10.42 86
2023 Q1 36,701,197 $255,777,503 +$175,104,339 $6.97 81
2022 Q4 11,606,048 $70,002,654 +$26,244,613 $6.03 79
2022 Q3 7,148,145 $56,407,292 -$15,368,475 $7.88 76
2022 Q2 8,406,419 $114,404,583 -$92,528,445 $13.61 79
2022 Q1 14,444,471 $283,158,200 -$10,020,593 $19.61 103
2021 Q4 14,649,709 $503,022,059 +$22,422,488 $34.31 99
2021 Q3 13,728,835 $749,897,430 -$11,662,295 $54.62 104
2021 Q2 10,743,822 $789,319,360 -$28,307,983 $73.48 104
2021 Q1 14,053,252 $1,284,956,347 +$337,575,946 $91.46 83
2020 Q4 7,249,066 $588,215,271 -$18,687,692 $81.07 58
2020 Q3 7,605,083 $355,419,000 +$354,563,000 $46.55 42
2020 Q2 108 $8,000 $74.07 1
2020 Q1 108 $8,000 $74.07 1
2019 Q4 108 $8,000 $74.07 1
2019 Q3 108 $8,000 $74.07 1
2019 Q2 108 $8,000 $74.07 1
2019 Q1 108 $8,000 $74.07 1